Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Pharmacom ApS
APS
Dissolved
CVR 40251480
Betonvej 10
Activities of agents involved in non-specialised wholesale · NACE 4619
Est. 2019
1 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2023
DKK 837K
+7% vs 2022
EBITDA margin
5.7%
-63% vs 2022
Equity ratio
25.2%
Financial strength
Net profit 2023
DKK 8K
-21% vs 2022
EBITDA — year on year
DKK millions
0M
1M
1M
2M
3M
0M
2020
2M
+200%
2021
0M
-100%
2022
0M
0%
2023
Key figures
Annual report 2023
Revenue
DKK 837K
+7%
EBITDA
DKK 48K
-63%
Net profit
DKK 8K
-21%
Total assets
DKK 359K
-59%
Equity
DKK 90K
+10%
Employees
1
—
Company information
Legal name
Pharmacom ApS
CVR number
40251480
Legal form
Anpartsselskab
NACE code
4619 · Activities of agents involved in non-specialised wholesale
Founded
8. februar 2019
Share capital
DKK 50.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Contact
Address
Betonvej 10
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Activities of agents involved in non-specialised wholesale
Companies in Roskilde
All Denmark companies
Revenue
DKK millions
0M
1M
1M
2M
2M
0M
2020
2M
2021
1M
2022
1M
2023
EBITDA
DKK millions
0M
1M
1M
2M
2M
0M
2020
2M
2021
0M
2022
0M
2023
Income statement
DKK thousands
Item
2020
2021
2022
2023
Revenue
27
2.484
779
837
Staff expenses
-0
-760
-649
-789
EBITDA
27
1.724
129
48
Depreciation & amort.
-0
-85
-76
-28
EBIT
27
1.639
53
20
Net financials
-0
-27
-36
-6
Profit before tax
27
1.612
17
14
Tax
10
357
6
5
Net profit
17
1.255
11
8
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
Total assets
432
1.849
879
359
Equity
67
1.322
82
90
Long-term debt
0
0
0
0
Short-term debt
365
524
797
269
Total debt
365
524
797
269
Financial ratios
5-year trend
EBITDA margin
5.7%
This company
15.8%
Market median
-64% vs market
2020
2023
Equity ratio
25.2%
This company
38.2%
Market median
-34% vs market
2020
2023
Return on equity
9.2%
This company
18.4%
Market median
-50% vs market
2020
2023
Net profit margin
1.0%
This company
8.1%
Market median
-88% vs market
2020
2023
Asset turnover
2.33×
This company
1.12×
Market median
+108% vs market
2020
2023
Debt / equity
2.97×
This company
0.62×
Market median
-379% vs market
2020
2023
Annual reports & filings
Annual report 2023
Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2019-02-08 – 2020-06-30
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Søren Nikolajsen
Individual
100.0%
100.0%
2019
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Pharmacom ApS also hold positions in
0
other companies.
Person
Role here
Other companies